<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pfizer - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/pfizer/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/pfizer/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Tue, 28 Mar 2023 15:17:37 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>pfizer - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/pfizer/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Approvato il primo spray nasale contro l’emicrania, lo lancia Pfizer</title>
		<link>https://www.newpharmaitaly.it/approvato-il-primo-spray-nasale-contro-lemicrania-lo-lancia-pfizer/</link>
		
		<dc:creator><![CDATA[Marco Devastato]]></dc:creator>
		<pubDate>Tue, 28 Mar 2023 15:17:34 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Salute]]></category>
		<category><![CDATA[Emicrania]]></category>
		<category><![CDATA[pfizer]]></category>
		<category><![CDATA[salute]]></category>
		<guid isPermaLink="false">https://www.newpharmaitaly.it/?p=50982</guid>

					<description><![CDATA[<p>Gli studi clinici concordano: lo spray nasale lanciato da Pfizer aiuta a combattere l’emicrania. È una svolta nel mondo farmaceutico, dato che per la prima volta è stato approvato un farmaco ad azione rapida che aiuta a combattere questa condizione senza essere assunto per via orale.</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/approvato-il-primo-spray-nasale-contro-lemicrania-lo-lancia-pfizer/">Approvato il primo spray nasale contro l’emicrania, lo lancia Pfizer</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
